Eptacog Alfa (Activated)

3 trials 3 recruiting BHaematology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

4 Sponsors

12 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Oversight events:

2 temporary halts across 1 trial

View oversight register →

Indications tested

Von Willebrand´s disease 1

Sponsors using this IMP

Emory University 1 F. Hoffmann-La Roche AG 1 HZRM Haemophilie-Zentrum Rhein Main GmbH 1 University Of Cincinnati College Of Medicine 1

All trials

3 total

A Study to assess safety and effectiveness of Emicizumab in Patients with Type 3 Von Willebrand Disease Recruiting

2024-515622-80-00 Phase III 8 countries F. Hoffmann-La Roche AG
Recombinant coagulation Factor VIIa administered at the earliest time for the treatment of stroke caused by bleeding in the brain - FASTEST… Recruiting

2024-517383-28-00 Phase III 2 countries University Of Cincinnati College Of Medicine
An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito… Recruiting

2024-516741-39-00 Phase IV 7 countries Emory University; HZRM Haemophilie-Zentrum Rhein Main GmbH

Showing 1–3 of 3 trials

← All drugs A–Z